Causes of Multiple Sclerosis
User reported causes of Multiple Sclerosis based on their intuition.
| Cause | Agree |
|---|---|
| Stress | 89% |
| Heat | 78% |
| Neurological | 69% |
| Compromised Immune System | 58% |
| Low Vitamin D Level | 53% |
| Environmental | 48% |
| Fever | 46% |
| Virus/Sickness Triggers Relapse | 44% |
| Possibly Born With the Illness / Genetic Predisposition | 43% |
| High Humidity | 40% |
| Weather/Seasonal Changes | 39% |
| Difficulties at Work | 37% |
| Western Diet | 33% |
| Epstein Barr Virus | 30% |
| Dehydration | 28% |
| Physical Trauma | 27% |
| Pshychological Trauma | 27% |
| USA Vegetables Being Vitamin Depleted | 23% |
| Sugar Addiction | 18% |
| Chronic Cerebrospinal Venous Insufficiency (CCSVI) | 18% |
| Growth Hormones in Meats | 18% |
| Caregiving to Family Member | 17% |
| Vaccination | 17% |
| Surgery | 15% |
| Auto Accident | 15% |
| Lyme Disease And/or Co-Infections | 13% |
| Post-Traumatic Stress Disorder (PTSD) | 10% |
| Repeated Head Trauma | 10% |
| Death of Child | 8% |
| Hepatitis Vaccination or Booster | 8% |
| Death of Spouse | 6% |
| Purpera | 2% |
Conditions Resulting from Multiple Sclerosis
User-reported conditions resulting from Multiple Sclerosis based on their intuition.
| Resulting Condition | Agree |
|---|---|
| Herniated Disc | 87% |
| Plantar Fasciitis | 70% |
| Chronic Cerebrospinal Venous Insufficiency (CCSVI) | 49% |
| Urinary Incontinence | 21% |
| Neurological Problems and Chronic Pain | 18% |
| Vertigo | 16% |
| Neuropathy | 14% |
| Chronic Pain Syndrome | 7% |
| Constipation | 6% |
| Dizziness/Lightheadedness | 6% |
| Myofascial Pain Syndrome | 5% |
| Athlete's Foot | 5% |
| Scoliosis | 5% |
| Night Cramps | 5% |
| Hearing Loss | 5% |
| Cold Intolerance | 5% |
| Chronic Fatigue Syndrome | 4% |
| Fatigue | 4% |
| Depression | 3% |
| Rheumatoid Arthritis | 3% |
| Shoulder Pain | 3% |
| Tinnitus | 3% |
| Neck Pain | 3% |
| Back Pain | 2% |
| Lower Back Pain | 2% |
| Allergies | 1% |
| Anxiety | 1% |
| Infertility | 0% |
| Occipital Neuritis | 0% |
Treatments
User-reported effectiveness in treating Multiple Sclerosis
| Treatment | Major Improvement | Moderate Improvement | Much Worse | No Effect | Worse | Responses |
|---|---|---|---|---|---|---|
| Physical Therapy | 13% | 49% | 0% | 30% | 8% | 106 |
| Rest | 22% | 52% | 0% | 22% | 3% | 203 |
| Exercise | 19% | 43% | 3% | 29% | 6% | 193 |
| Acupuncture | 2% | 32% | 7% | 54% | 5% | 41 |
| Low Dose Naltrexone (LDN) | 50% | 32% | 2% | 14% | 3% | 125 |
| Neurontin (Gabapentin) | 11% | 38% | 8% | 38% | 5% | 61 |
| Corticosteroids | 23% | 45% | 6% | 21% | 6% | 107 |
| Vitamin D | 9% | 22% | 1% | 66% | 2% | 125 |
| Provigil | 19% | 37% | 11% | 27% | 5% | 62 |
| Massage Therapy | 22% | 46% | 0% | 28% | 4% | 46 |
| Trigger Point Injections | 17% | 50% | 0% | 17% | 17% | 6 |
| Paracetamol | 0% | 37% | 0% | 60% | 3% | 30 |
| Baclofen | 16% | 24% | 3% | 46% | 11% | 79 |
| Xanax | 17% | 33% | 6% | 39% | 6% | 18 |
| Occupational Therapy | 7% | 36% | 5% | 48% | 5% | 42 |
| Estrogen Therapy | 13% | 25% | 13% | 50% | 0% | 8 |
| Chinese Herbs | 5% | 25% | 5% | 65% | 0% | 20 |
| Homeopathy | 15% | 20% | 0% | 60% | 5% | 20 |
| Cannabis | 23% | 40% | 4% | 28% | 4% | 47 |
| Diet Changes | 17% | 38% | 2% | 39% | 3% | 180 |
| Tysabri | 21% | 21% | 14% | 41% | 3% | 29 |
| Copaxone | 9% | 19% | 4% | 60% | 9% | 112 |
| Counseling | 14% | 45% | 2% | 33% | 7% | 58 |
| Ayurveda | 0% | 100% | 0% | 0% | 0% | 4 |
| Celexa | 8% | 33% | 0% | 33% | 25% | 12 |
| Avonex | 3% | 11% | 28% | 48% | 9% | 64 |
| Pool, Water Therapy | 23% | 57% | 0% | 13% | 7% | 30 |
| IV Steroids | 29% | 38% | 6% | 22% | 5% | 82 |
| Acupressure | 15% | 77% | 0% | 8% | 0% | 13 |
| Intravenous Solution (Calcium-EAP) | 75% | 0% | 0% | 25% | 0% | 4 |
| Gilenya | 50% | 50% | 0% | 0% | 0% | 4 |
| Grain/legume/dairy-Free Diet (Aka Paleo) | 20% | 40% | 0% | 40% | 0% | 25 |
| Nuvigil | 44% | 22% | 11% | 11% | 11% | 9 |
| CCSVI (Chonic Cerebrospinal Venous Insufficiency) | 60% | 0% | 0% | 0% | 40% | 5 |
| Implanted Baclofen Pump | 0% | 100% | 0% | 0% | 0% | 1 |
| Plasma Exchange | 0% | 67% | 0% | 33% | 0% | 3 |
| Campath | 0% | 50% | 0% | 50% | 0% | 2 |
| Bee Sting Treatment | 0% | 0% | 0% | 100% | 0% | 1 |
| Tonic Water | 0% | 0% | 0% | 100% | 0% | 1 |
| Tizanidine | 0% | 61% | 0% | 22% | 17% | 18 |
| IVIG | 50% | 0% | 50% | 0% | 0% | 2 |
| Carbamazepine | 0% | 40% | 20% | 40% | 0% | 5 |
| Hyperbaric Oxygenation | 0% | 50% | 17% | 17% | 17% | 6 |
| 4-Aminopyridine | 8% | 23% | 8% | 54% | 8% | 13 |
| Novantrone | 18% | 9% | 18% | 45% | 9% | 11 |
| Cytoxan/Endoxan | 0% | 0% | 100% | 0% | 0% | 3 |
| Amantadine | 8% | 18% | 8% | 50% | 18% | 40 |
| Rebif | 8% | 16% | 21% | 41% | 14% | 63 |
| Betaseron | 0% | 9% | 24% | 53% | 15% | 34 |
Outcomes
Below is the degree of change seen after Multiple Sclerosis is higher than average.
|
|
Predictors
Below is the change in Multiple Sclerosis seen after the predictor is higher than average.
|
|
Outcomes Label
Predictors Label
Multiple Sclerosis Info
| Property | Value |
|---|---|
| Variable Name | Multiple Sclerosis |
| Aggregation Method | MEAN |
| Analysis Performed At | 2020-03-02 |
| Duration of Action | 24 hours |
| Maximum Allowed Value | 5 out of 5 |
| Minimum Allowed Value | 1 out of 5 |
| Number of Aggregate Predictors | 0 |
| Number of Aggregate Outcomes | 0 |
| Number of Measurements | 0 |
| Number of Measurements (including those generated by tagged, joined, or child variables) | 0 |
| Public | true |
| Onset Delay | 0 seconds |
| Unit | 1 to 5 Rating |
| User Variables | 0 |
| Variable Category | Symptoms |
| Variable ID | 86869 |